These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7294833)
1. Immunochemistry of the Lewis-blood-group system: partial characterization of Le(a)-, Le(b)-, and H-type 1 (LedH)-blood-group active glycosphingolipids from human plasma. Hanfland P; Graham HA Arch Biochem Biophys; 1981 Aug; 210(1):383-95. PubMed ID: 7294833 [No Abstract] [Full Text] [Related]
2. Immunochemistry of the Lewis-blood-group system: mass spectrometric analysis of permethylated Le(a)-, Le(b)-, and H-type 1 (LedH) blood-group active and related glycosphingolipids from human plasma. Egge H; Hanfland P Arch Biochem Biophys; 1981 Aug; 210(1):396-404. PubMed ID: 7294834 [No Abstract] [Full Text] [Related]
3. Immunochemistry of the Lewis-blood-group system: proton nuclear magnetic resonance study of plasmatic Lewis-blood-group-active glycosphingolipids and related substances. Dabrowski J; Hanfland P; Egge H; Dabrowski U Arch Biochem Biophys; 1981 Aug; 210(1):405-11. PubMed ID: 7294835 [No Abstract] [Full Text] [Related]
4. Immunochemistry of the Lewis blood-group system: isolation and structures of Lewis-c active and related glycosphingolipids from the plasma of blood-group O Le(a-b-) nonsecretors. Hanfland P; Kordowicz M; Peter-Katalinic J; Pfannschmidt G; Crawford RJ; Graham HA; Egge H Arch Biochem Biophys; 1986 May; 246(2):655-72. PubMed ID: 2423032 [TBL] [Abstract][Full Text] [Related]
5. Immunochemistry of the Lewis blood-group system: investigations on the Lec antigen. Hanfland P; Graham HA; Crawford RJ; Schenkel-Brunner H FEBS Lett; 1982 Jun; 142(1):77-80. PubMed ID: 6179793 [No Abstract] [Full Text] [Related]
6. Structures of fucose-containing ceramide pentasaccharides from the plasma of blood group O Le(a-b-) nonsecretors. Pfannschmidt G; Peter-Katalinić J; Kordowicz M; Egge H; Dabrowski J; Dabrowski U; Hanfland P FEBS Lett; 1984 Aug; 174(1):55-60. PubMed ID: 6468659 [TBL] [Abstract][Full Text] [Related]
7. Screening for the presence of polyglycosylceramides in various tissues: partial characterization of blood group-active complex glycosphingolipids of rabbit and dog small intestines. Miller-Podraza H; Stenhagen G; Larsson T; Andersson C; Karlsson KA Glycoconj J; 1997 Feb; 14(2):231-9. PubMed ID: 9111140 [TBL] [Abstract][Full Text] [Related]
8. Detection of combined ABH and Lewis glycosphingolipids in sera of H-deficient donors. Bernoco M; Danilovs J; Terasaki PI; Cartron JP; Mollicone R; Le Pendu J; Oriol R Vox Sang; 1985; 49(1):58-66. PubMed ID: 2409675 [TBL] [Abstract][Full Text] [Related]
9. Isolation and purification of Lewis blood-group active glycosphingolipids from the plasma of human O Leb individuals. Hanfland P Eur J Biochem; 1978 Jun; 87(1):161-70. PubMed ID: 668686 [No Abstract] [Full Text] [Related]
10. Identification of a blood group A active hexaglycosylceramide with a type 1 carbohydrate chain in plasma of an A1 Le(a-b-) secretor. Jovall PA; Lindström K; Pascher I; Pimlott W; Samuelsson BE Arch Biochem Biophys; 1987 Sep; 257(2):409-15. PubMed ID: 3662532 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of Le(a) and Le(b) antigens in human saliva. Wang B; Akiyama K; Kimura H Vox Sang; 1994; 66(4):280-6. PubMed ID: 7772103 [TBL] [Abstract][Full Text] [Related]
12. Chemical fingerprinting of glycosphingolipids in meconium of a human blood group O Le(a-b+) secretor. Angström J; Falk KE; Karlsson KA; Larson G Biochim Biophys Acta; 1982 Mar; 710(3):428-36. PubMed ID: 7074123 [TBL] [Abstract][Full Text] [Related]
13. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Kitamura K; Stockert E; Garin-Chesa P; Welt S; Lloyd KO; Armour KL; Wallace TP; Harris WJ; Carr FJ; Old LJ Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12957-61. PubMed ID: 7809154 [TBL] [Abstract][Full Text] [Related]
14. Alterations of glycosphingolipid-based blood group antigen expression on erythrocytes and in plasma studied on consecutive samples after a blood group O to A bone marrow transplantation. Lindström K; Shanwell A; Jacobsson A; Lönnqvist B; Samuelsson BE Glycobiology; 1992 Dec; 2(6):529-34. PubMed ID: 1472759 [TBL] [Abstract][Full Text] [Related]
15. Characterization of anti-Leb antibody purified from serum of immunized rabbits. Hosomi O; Yazawa S; Takeya A Jpn J Med Sci Biol; 1991 Aug; 44(4):187-93. PubMed ID: 1821427 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and immunochemical studies of the expression of glycosphingolipid-based ABH and related antigens in normal cells and in plasma. Lindström K; Rydberg L; Samuelsson BE Ann Inst Pasteur Immunol; 1987; 138(6):857-61. PubMed ID: 3329914 [No Abstract] [Full Text] [Related]
17. The chemical basis for expression of the sialyl-Le(a) antigen. Zopf D; Hansson GC Adv Exp Med Biol; 1988; 228():657-76. PubMed ID: 3051923 [TBL] [Abstract][Full Text] [Related]
18. Fucosylated glycosphingolipids of human myeloid cells. Kong RK; Barrios A; Knapp W; Macher BA Arch Biochem Biophys; 1993 Feb; 300(2):677-83. PubMed ID: 8434948 [TBL] [Abstract][Full Text] [Related]
19. Tissue specificity of glycosphingolipids as expressed in pancreas and small intestine of blood group A and B human individuals. Breimer ME Arch Biochem Biophys; 1984 Jan; 228(1):71-85. PubMed ID: 6198960 [TBL] [Abstract][Full Text] [Related]
20. Isolation and purification of Lea blood-group active and related glycolipids from human plasma of blood-group A Lea individuals. Hanfland P; Kladetzky RG; Egli H Chem Phys Lipids; 1978 Sep; 22(2):141-51. PubMed ID: 709700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]